Agenix appoints board, aims to strengthen blood business
13 May, 2003 by Pete YoungListed biotech Agenix is ringing in changes to bolster its current blood diagnostics business while promoting the progress of its intended next-generation product, the Thromboview blood clot-imaging agent.
Aust stem cell laws 'enlightened': US bioethicist
09 April, 2003 by Melissa TrudingerA leading US bioethicist has praised Australia's new stem cell laws, describing them as enlightened.
Singapore cord blood firm to set up in Australia
08 April, 2003 by Jeremy TorrSingapore-based CordLife is looking to establish a local cord blood facility for as a precursor to expanding Australian operations in stem cell (haematopoietic stem cells or HSC) research.
Norwood Abbey spins out immunology project
03 April, 2003 by Melissa TrudingerNorwood Abbey has spun out its immunology project into a separate company, which will be listed in Europe or the USA within the next 12 months.
Oncomab, Medarex to develop antibodies
19 March, 2003 by Melissa TrudingerPrima BioMed (ASX:PRR) subsidiary Oncomab has entered into a joint venture with US humanised antibody company Medarex to co-develop and commercialise fully human antibodies for the treatment of cancer.
SARS agent still unidentified
18 March, 2003 by Graeme O'NeillScientists at the National Centres for Disease Control (CDC) in Atlanta, Georgia, are working "around the clock" in collaboration with World Health Organisation researchers and international disease reference laboratories to identify the infectious agent responsible for an outbreak of a potentially deadly respiratory disease in south-east Asia.
Monash research targets vaccine against 'stealth microbe'
06 March, 2003 by Graeme O'NeillResearchers at Monash University have begun sifting through the database from Australia's first bacterial genome project, looking for targets for a vaccine against an unusual microbe that can kill, or leave survivors chronically depressed.
Colman to address Sydney conference
03 March, 2003 by Iain ScottCloning pioneer Alan Colman, the director of research programs with Singapore company ES Cell International, will visit Sydney in May to address a conference on prospects for stem cell therapy.
STEM CELL FEATURE PART 2: Tangled up in red?
17 February, 2003 by Pete YoungFor the second of our two-part series examining Australia's new laws on embryonic stem cell research and human cloning, Pete Young asked medical researchers, IVF clinics and companies developing stem cell-related products for their views on the impact of the legislation.
STEM CELL FEATURE PART 1: Legislating the embryo
13 February, 2003 by Pete YoungIn the first part of a two-part series about Australia's new stem cell laws, Pete Young looks at the NHMRC's role and who will need to apply for a licence to do the research.
Synchrotron becoming drug design essential, say researchers
12 February, 2003 by Melissa TrudingerCSIRO structural biologist Jose Varghese believes that synchrotrons are essential tools for finding out how proteins work, and designing drugs to specifically interact with them.
ES Cell licenses US diabetes technology
30 January, 2003 by Pete YoungStem cell-based regenerative medicine company ES Cell International (ESI) has licensed cutting-edge US technology to speed its path to the commercialisation of a diabetes cell replacement therapy.
Chemeq broadens pipeline with sunscreen product
28 January, 2003 by Melissa TrudingerPerth-based biotech Chemeq has expanded its pipeline with the development of a sunscreen and an after-sun emollient based on its proprietary polymer chemistry platform.
Adult stem cells hold promise in future MS therapy
21 January, 2003 by Susan WilliamsonResearchers at Sydney's St Vincent's Hospital have found for the first time that adult stem cells can be differentiated into the white matter forming cells of the brain, the oligodendrocytes.
Arthritis vaccine breakthrough claimed by Qld team
16 January, 2003 by Pete YoungAn Australian research team is claiming a breakthrough in developing a therapeutic vaccine against autoimmune diseases including rheumatoid arthritis.
